LinkMed

LinkMed

Innovative cancer therapy through advanced radioactive drugs, enhancing health and well-being.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

JPY300m

Valuation: JPY7.5b

Series B
Total Funding000k
More about LinkMed
Made with AI
Edit

Link Med Co., Ltd. specializes in the development and manufacture of advanced radioactive drugs aimed at innovative cancer therapy. Operating in the healthcare and pharmaceutical market, Link Med serves hospitals, clinics, and medical research institutions. The company leverages cutting-edge science to create effective treatments that improve patient outcomes and overall well-being. Link Med's business model revolves around the production and sale of these specialized drugs, generating revenue through direct sales to healthcare providers and partnerships with medical institutions. The company is committed to advancing medical science and providing state-of-the-art solutions for cancer treatment.

Keywords: radioactive drugs, cancer therapy, healthcare, pharmaceutical, medical research, patient outcomes, advanced treatments, healthcare providers, medical institutions, innovative solutions.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads